Mesothelioma News

News headlines courtesy the Mesothelioma Center.

ADAO Applauds Assembly Committee on Natural Resources for Passing Resolution to Repeal the Designation of Asbestos Laden Serpentine as the California State Rock: June 25, 2010 - The Asbestos Disease Awareness Organization (ADAO) applauds both Senator Gloria Romero for authoring SB 624 and the Assembly Committee on Natural Resources for passing this legislation to remove serpentine, the host rock of asbestos, as California?s official state rock, supporting the eradication of asbestos to promote public health. ?ADAO dedicates our efforts on this campaign [...]
Senator Max Baucus Honored by Mesothelioma Applied Research Foundation: June 18, 2010 - On June 11, 2010 Senator Max Baucus, the United States Senator from Montana, received the Bruce Vento Hope Builder Award during the International Symposium on Malignant Mesothelioma. This event, hosted by the Mesothelioma Applied Research Foundation (Meso Foundation) took place in Washington, DC from June 10 ? 12, 2010 at the Omni Shoreham Hotel. This [...]
Experts Urge Canada to Change Deadly Asbestos Policy: May 10, 2010 - World renowned experts, asbestos victims, labour, political leaders, academic researchers and health care providers will gather on Parliament Hill on May 12 to demand that Canada change its shameful course on asbestos, at a 11 a.m. press conference and subsequent rally. They will also call for just transition policies for communities relying on this industry. [...]
MolMed starts Phase III trial of NGR-hTNF in mesothelioma: April 20, 2010 - MolMed S.p.A. (Milan:MLM) announces the treatment of the first patient in a pivotal Phase III trial (NGR015) of its investigational antitumour drug NGR-hTNF in malignant pleural mesothelioma, a condition linked with repeated exposition to asbestos fibers. Claudio Bordignon, MolMed?s chairman and CEO, comments: ?We are really proud of this important milestone, as NGR-hTNF may represent [...]
microRNAs Shown To Have Powerful Potential as Diagnostic and Prognostic Markers In A Variety Of Cancer Indications: April 13, 2010 - Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today it will present multiple posters at the upcoming American Association of Cancer Research’s (AACR) 101st Annual Meeting to be held at the Walter E. Washington Convention Center in Washington, D.C. from April 17-21, 2010. The posters will include data on [...]
ADAO Praises Senate for Passage of Sixth Annual Resolution that Establishes ?National Asbestos Awareness Week?: March 26, 2010 - The Asbestos Disease Awareness Organization (ADAO), the largest U.S. organization serving as the voice of asbestos victims, today applauds the United State Senate for the passage of S.RES.427, a resolution that declares the first week of April as ?National Asbestos Awareness Week? and urges the Surgeon General to warn and educate Americans of the severe [...]
Bionomics To Initiate BNC105 Phase II Trial In Mesothelioma Patients: March 26, 2010 - Bionomics, an Australian drug discovery and development company, is set to initiate the second Phase II clinical trial of vascular disrupting agent BNC105 in patients with advanced mesothelioma. Bionomics has already commenced Phase II testing of the anti-cancer properties of BNC105 in renal cancer in the US. The commencement of these two Phase II trials [...]
New NCCN Guidelines? for Malignant Pleural Mesothelioma Presented at Annual Conference: March 15, 2010 - A new addition to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?), the NCCN Guidelines for Malignant Pleural Mesothelioma (MPM), was presented at the NCCN 15th Annual Conference. Lee M. Krug, MD of Memorial Sloan-Kettering Cancer Center and a member of the NCCN Guidelines Panel discussed recommended treatment options for patients with MPM as [...]
Mesothelioma Applied Research Foundation Funds Eight New Research Projects to Advance Critically-Needed Mesothelioma Treatments: February 24, 2010 - The Mesothelioma Applied Research Foundation (Meso Foundation) announced today awards of an additional $800,000 to researchers, at top national and international medical science centers, devoted to finding a cure for mesothelioma. This brings to almost $7 million the funds the Foundation has awarded to develop better treatment options for mesothelioma patients. To spur the research [...]
Joint Study by Rosetta Genomics and NYU Langone Medical Center Identifies Single microRNA Biomarker for Prognosis of Mesothelioma Patients: February 18, 2010 - Demonstrate potential of miR-29c* to act as an independent prognostic factor for time to progression as well as survival after surgery Ability to forecast outcomes for malignant pleural mesothelioma (MPM) may enable clinicians to provide aggressive therapy to the most appropriate patients Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced [...]

Mesotheleoma

mesotheleoma: did you mean mesothelioma? This rare cancer can be a tongue-twister to say, let alone spell. Have you have recently received a mesothelioma diagnosis? [Contact Us.]

Mesothelioma Lawyer

With a hundred years of ignoring, downplaying, and outright covering up of the dangers surrounding asbestos, mesothelioma attorneys have their work cut out for them. Depositions, medical evidence, and asbestos product order forms that are decades old need to be found and organized for each client's unique mesothelioma lawsuit.

Mesothelioma lawyers who have been involved since the beginning have the experience and knowledge to aggressively try your case. [Mesothelioma Lawyer.]

Contact Us

Last Updated: August 11, 2010. 10:06:49 am.

This information © 2002-2010 by the Asbestos Lawyers at Goldberg, Persky, & White, P.C. The content of this web site was developed as a service to mesothelioma patients and their families. Web site content has not been prepared or endorsed by physicians or licensed medical professionals. Nothing on this site should be taken as medical advice. Our staff are not physicians nor trained medical professionals and nothing they say should be taken as medical advice. The purpose of this site is to provide patients and their families with useful information and access to resources which may be helpful. Patients are encouraged to consult with their physician for medical advice and with an mesothelioma attorney for legal advice.